1. Home
  2. RBA vs RPRX Comparison

RBA vs RPRX Comparison

Compare RBA & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RB Global Inc.

RBA

RB Global Inc.

HOLD

Current Price

$99.95

Market Cap

18.8B

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$47.40

Market Cap

19.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBA
RPRX
Founded
1958
1996
Country
United States
United States
Employees
7900
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8B
19.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RBA
RPRX
Price
$99.95
$47.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$128.75
$47.75
AVG Volume (30 Days)
1.7M
3.4M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
1.23%
2.03%
EPS Growth
N/A
N/A
EPS
N/A
1.78
Revenue
N/A
$2,378,193,000.00
Revenue This Year
$4.52
$39.10
Revenue Next Year
$3.94
$5.02
P/E Ratio
$52.68
$25.87
Revenue Growth
N/A
5.06
52 Week Low
$87.87
$29.66
52 Week High
$119.58
$46.37

Technical Indicators

Market Signals
Indicator
RBA
RPRX
Relative Strength Index (RSI) 38.57 80.55
Support Level $97.48 $35.32
Resistance Level $106.54 N/A
Average True Range (ATR) 4.74 1.01
MACD -0.98 0.04
Stochastic Oscillator 16.15 98.79

Price Performance

Historical Comparison
RBA
RPRX

About RBA RB Global Inc.

RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: